SPIA
PAHC icon

Steward Partners Investment Advisory’s Phibro Animal Health PAHC Stock Holding History

Steward Partners Investment Advisory’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-67
Closed -$898 – 3393
2022
Q4 		$898 Buy
+67
New +$898 ﹤0.01% 3132

Other funds holding PAHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Steward Partners Investment Advisory's PAHC Position: Q1 2023 in Review

Steward Partners Investment Advisory sold out of Phibro Animal Health (PAHC) in Q1 2023, closing a stake of 67 shares — an estimated $898 sold.

Steward Partners Investment Advisory first reported a position in PAHC in Q4 2022 and held it in 1 quarter. The position peaked at $898 in Q4 2022. 133 funds tracked by Wall St. Rank hold PAHC as of Q1 2023.

  • Steward Partners Investment Advisory reported no remaining Phibro Animal Health position as of Q1 2023 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 67 Phibro Animal Health shares in Q1 2023, an estimated $898.
  • Steward Partners Investment Advisory first reported a position in Phibro Animal Health in Q4 2022 and held it in 1 quarter.
  • Steward Partners Investment Advisory's Phibro Animal Health position peaked at $898 in Q4 2022.
  • 133 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2023.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2023, filed 15 May 2023.